HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49658,
"recordsTotal": 49658,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-days_late&start=47700",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-days_late&start=47100",
"results": [
{
"registry_id": "NCT07355218",
"publication_url": "https://clinicaltrials.gov/study/NCT07355218",
"title": "A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-2)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "EMD Serono Research & Development Institute, Inc.",
"sponsor_slug": "emd-serono-research-development-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07631000",
"publication_url": "https://clinicaltrials.gov/study/NCT07631000",
"title": "A Phase 2, Single-arm Study of Cadonilimab and FLOT Chemotherapy in Patients With Locally Advanced, Resectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2029-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287982",
"publication_url": "https://clinicaltrials.gov/study/NCT07287982",
"title": "A Phase 2 Double-Blinded, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2029-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03307980",
"publication_url": "https://clinicaltrials.gov/study/NCT03307980",
"title": "A FACTOR IX (FIX) GENE TRANSFER, MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B",
"has_exemption": false,
"start_date": "2017-06-22",
"completion_date": "2029-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04776252",
"publication_url": "https://clinicaltrials.gov/study/NCT04776252",
"title": "A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once-daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study",
"has_exemption": false,
"start_date": "2021-09-15",
"completion_date": "2029-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04802759",
"publication_url": "https://clinicaltrials.gov/study/NCT04802759",
"title": "A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Breast Cancer (MORPHEUS-BREAST CANCER)",
"has_exemption": false,
"start_date": "2021-06-22",
"completion_date": "2029-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04669171",
"publication_url": "https://clinicaltrials.gov/study/NCT04669171",
"title": "A Global Multicenter Phase 1/2 Trial of EO2463, a Novel Microbial-Derived Peptide Therapeutic Vaccine, as Monotherapy, and in Combination With Lenalidomide and Rituximab, for Treatment of Patients With Indolent Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2021-07-05",
"completion_date": "2029-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Enterome",
"sponsor_slug": "enterome",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06599099",
"publication_url": "https://clinicaltrials.gov/study/NCT06599099",
"title": "Building Mood State Classifiers to Inform Deep Brain Stimulation of Treatment-Resistant Bipolar Depression",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayne Goodman MD",
"sponsor_slug": "wayne-goodman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07592611",
"publication_url": "https://clinicaltrials.gov/study/NCT07592611",
"title": "Deep Brain Stimulation in Treatment Resistant Schizophrenia",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03121001",
"publication_url": "https://clinicaltrials.gov/study/NCT03121001",
"title": "A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease",
"has_exemption": false,
"start_date": "2017-03-20",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03705585",
"publication_url": "https://clinicaltrials.gov/study/NCT03705585",
"title": "CVD 38000: Immunity, Microbiome, Epigenetics, and a Systems Biology Approach to the Study of Responses to Vaccination With Typhoid and/or Cholera",
"has_exemption": false,
"start_date": "2018-11-05",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04339764",
"publication_url": "https://clinicaltrials.gov/study/NCT04339764",
"title": "A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2020-09-23",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04692493",
"publication_url": "https://clinicaltrials.gov/study/NCT04692493",
"title": "A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RA-PRO Pragmatic Trial (RA-PROPR)",
"has_exemption": false,
"start_date": "2021-09-22",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05318573",
"publication_url": "https://clinicaltrials.gov/study/NCT05318573",
"title": "A Phase 2a Study With Safety Run-in to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FF-10832 Monotherapy or in Combination With Pembrolizumab in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2022-06-01",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fujifilm Pharmaceuticals U.S.A., Inc.",
"sponsor_slug": "fujifilm-pharmaceuticals-usa-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06016842",
"publication_url": "https://clinicaltrials.gov/study/NCT06016842",
"title": "A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2023-08-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05537220",
"publication_url": "https://clinicaltrials.gov/study/NCT05537220",
"title": "NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa",
"has_exemption": false,
"start_date": "2023-10-11",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05890729",
"publication_url": "https://clinicaltrials.gov/study/NCT05890729",
"title": "A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations",
"has_exemption": false,
"start_date": "2023-11-10",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xentria, Inc.",
"sponsor_slug": "xentria-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06420297",
"publication_url": "https://clinicaltrials.gov/study/NCT06420297",
"title": "A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome",
"has_exemption": false,
"start_date": "2024-03-11",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940207",
"publication_url": "https://clinicaltrials.gov/study/NCT05940207",
"title": "Safety Testing of Hydrogen Peroxide-Generating e-Bandage on Normal Human Skin",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06545136",
"publication_url": "https://clinicaltrials.gov/study/NCT06545136",
"title": "A Multicenter, Long-term, Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral Vector (FLT201) in Subjects With Gaucher Disease (GALILEO-2)",
"has_exemption": false,
"start_date": "2024-05-13",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spur Therapeutics",
"sponsor_slug": "spur-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06295731",
"publication_url": "https://clinicaltrials.gov/study/NCT06295731",
"title": "A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First Line Treatment for Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Expressing PD-L1 (CPS ≥20) (HexAgon-HN)",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Inhibrx Biosciences, Inc",
"sponsor_slug": "inhibrx-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06374875",
"publication_url": "https://clinicaltrials.gov/study/NCT06374875",
"title": "A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ali Aminian",
"sponsor_slug": "ali-aminian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06485206",
"publication_url": "https://clinicaltrials.gov/study/NCT06485206",
"title": "A Clinical Investigation Evaluating Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Highridge Medical",
"sponsor_slug": "highridge-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06789848",
"publication_url": "https://clinicaltrials.gov/study/NCT06789848",
"title": "Phase II Basket Trial of Ligufalimab (AK117) and Cadonilimab (AK104) in Advanced Hepatobiliary Cancers",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06682442",
"publication_url": "https://clinicaltrials.gov/study/NCT06682442",
"title": "Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06604520",
"publication_url": "https://clinicaltrials.gov/study/NCT06604520",
"title": "Functional Neuroimaging to Examine Affective Symptoms and Cognition in Frontotemporal Dementia",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907290",
"publication_url": "https://clinicaltrials.gov/study/NCT06907290",
"title": "A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirum Pharmaceuticals, Inc.",
"sponsor_slug": "mirum-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06890598",
"publication_url": "https://clinicaltrials.gov/study/NCT06890598",
"title": "A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination With Standard of Care Immunotherapy in Participants With Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966401",
"publication_url": "https://clinicaltrials.gov/study/NCT06966401",
"title": "A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06768905",
"publication_url": "https://clinicaltrials.gov/study/NCT06768905",
"title": "IOMAB-ACT: A Phase Ib/II Multi-institutional Study of 131 I-Apamistamab Followed by CD19-Targeted CAR-T Cell Therapy for Patients With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)",
"has_exemption": false,
"start_date": "2025-04-25",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06812715",
"publication_url": "https://clinicaltrials.gov/study/NCT06812715",
"title": "Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter MacCallum Cancer Centre, Australia",
"sponsor_slug": "peter-maccallum-cancer-centre-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06512194",
"publication_url": "https://clinicaltrials.gov/study/NCT06512194",
"title": "An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Charles Raison",
"sponsor_slug": "charles-raison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07059065",
"publication_url": "https://clinicaltrials.gov/study/NCT07059065",
"title": "A Post-market, Prospective, Controlled, Multicenter Clinical Study to Evaluate Radiographic Fusion of FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute in Subjects Who Undergo a Lumbar Posterolateral Fusion Surgery",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy Synthes Products, Inc.",
"sponsor_slug": "depuy-synthes-products-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899165",
"publication_url": "https://clinicaltrials.gov/study/NCT06899165",
"title": "Processing Intergenerational Trauma With Psilocybin-Assisted Therapy",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rachel Yehuda",
"sponsor_slug": "rachel-yehuda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218796",
"publication_url": "https://clinicaltrials.gov/study/NCT07218796",
"title": "A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SpyGlass Pharma, Inc.",
"sponsor_slug": "spyglass-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961357",
"publication_url": "https://clinicaltrials.gov/study/NCT06961357",
"title": "Phase I/II Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (TIL) for Patients With Advanced Melanoma",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174336",
"publication_url": "https://clinicaltrials.gov/study/NCT07174336",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY4064809 Combined With a CDK4/6 Inhibitor and Endocrine Therapy in Adults With HR+, HER2-Advanced Breast Cancer With a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285694",
"publication_url": "https://clinicaltrials.gov/study/NCT07285694",
"title": "An Open-label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients With Castration Resistant Prostate Cancer (CRPC)",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arsenal Biosciences, Inc.",
"sponsor_slug": "arsenal-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954129",
"publication_url": "https://clinicaltrials.gov/study/NCT06954129",
"title": "Markers of Nephrotoxicity During Treatment With Antibiotic Combinations: A Pragmatic Clinical Trial",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875128",
"publication_url": "https://clinicaltrials.gov/study/NCT06875128",
"title": "An Open-label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Induction Treatment With Melphalan/HDS Followed by Consolidation Treatment With Eribulin or Vinorelbine or Capecitabine Versus Eribulin or Vinorelbine or Capecitabine Alone in Patients With Metastatic Breast Cancer With Liver Dominant Disease",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Delcath Systems Inc.",
"sponsor_slug": "delcath-systems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07397338",
"publication_url": "https://clinicaltrials.gov/study/NCT07397338",
"title": "A Phase 1/2 Open-Label, Multicenter Study of RAS(ON) Inhibitors in Combination With Ivonescimab With or Without Other Anti-Cancer Agents in Patients With Solid Tumors",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07436156",
"publication_url": "https://clinicaltrials.gov/study/NCT07436156",
"title": "SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.",
"has_exemption": false,
"start_date": "2026-02-12",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Route 92 Medical, Inc.",
"sponsor_slug": "route-92-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07491497",
"publication_url": "https://clinicaltrials.gov/study/NCT07491497",
"title": "A Phase 1/2, Dose Escalation and Expansion Study of TRI-611, an Oral ALK Molecular Glue Degrader in Participants With Advanced ALK-Positive NSCLC",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TRIANA Biomedicines, Inc.",
"sponsor_slug": "triana-biomedicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07504796",
"publication_url": "https://clinicaltrials.gov/study/NCT07504796",
"title": "A Multi-center Trial Evaluating the ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab for Advanced Melanoma",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07558733",
"publication_url": "https://clinicaltrials.gov/study/NCT07558733",
"title": "Open-Label Umbrella Study to Evaluate Safety and Efficacy of Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07424092",
"publication_url": "https://clinicaltrials.gov/study/NCT07424092",
"title": "Intratumoral DNX-2401 Administration for Recurrent and Refractory High Grade Brain Tumors in Pediatric and Young Adult Patients",
"has_exemption": false,
"start_date": "2026-05-12",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Clinica Universidad de Navarra, Universidad de Navarra",
"sponsor_slug": "clinica-universidad-de-navarra-universidad-de-navarra",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07612215",
"publication_url": "https://clinicaltrials.gov/study/NCT07612215",
"title": "Elacestrant in Advanced Triple Positive Breast Cancer, a Phase II Evaluation (ELATE)",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773936",
"publication_url": "https://clinicaltrials.gov/study/NCT06773936",
"title": "A Phase II Trial of Asciminib, Dasatinib, Prednisone, and Blinatumomab for Participants With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07525206",
"publication_url": "https://clinicaltrials.gov/study/NCT07525206",
"title": "An Open-Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Plus Bevacizumab to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07574632",
"publication_url": "https://clinicaltrials.gov/study/NCT07574632",
"title": "The RESILIENT Scoliosis Brace System Clinical Trial (RESILIENT)",
"has_exemption": false,
"start_date": "2026-05-28",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thinks Works, PBC",
"sponsor_slug": "thinks-works-pbc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07472439",
"publication_url": "https://clinicaltrials.gov/study/NCT07472439",
"title": "Randomized Controlled Trial of the Auryon Atherectomy System Used in Combination With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07566234",
"publication_url": "https://clinicaltrials.gov/study/NCT07566234",
"title": "Myopia Prevention Study in Chinese Population With Dual Focus Myopia Control Lenses.",
"has_exemption": false,
"start_date": "2026-06-06",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CooperVision International Limited (CVIL)",
"sponsor_slug": "coopervision-international-limited-cvil",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071935",
"publication_url": "https://clinicaltrials.gov/study/NCT07071935",
"title": "A Pilot Randomized Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07587242",
"publication_url": "https://clinicaltrials.gov/study/NCT07587242",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (Delpacibart Zotadirsen) for the Treatment of DMD With Gene Mutations Amenable to Exon 44 Skipping",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021989",
"publication_url": "https://clinicaltrials.gov/study/NCT07021989",
"title": "Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael Spinner, MD",
"sponsor_slug": "michael-spinner-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07501078",
"publication_url": "https://clinicaltrials.gov/study/NCT07501078",
"title": "Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Muhammad N Aslam, MD",
"sponsor_slug": "muhammad-n-aslam-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07631572",
"publication_url": "https://clinicaltrials.gov/study/NCT07631572",
"title": "Phase II Clinical Trial of Cesium-131 Low-dose Rate Interstitial Brachytherapy as an Organ-preserving Irradiation Technique for Recurrent Cervical and Endometrial Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Denise Fabian",
"sponsor_slug": "denise-fabian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07665684",
"publication_url": "https://clinicaltrials.gov/study/NCT07665684",
"title": "Phase Ib/II Study of Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Health Network, Toronto",
"sponsor_slug": "university-health-network-toronto",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07592910",
"publication_url": "https://clinicaltrials.gov/study/NCT07592910",
"title": "A Phase 2, Open-label, Single-Arm Study of Mevrometostat Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Following Prior Androgen Receptor Pathway Inhibitor Therapy (MOMENT)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prostate Cancer Clinical Trials Consortium",
"sponsor_slug": "prostate-cancer-clinical-trials-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07608718",
"publication_url": "https://clinicaltrials.gov/study/NCT07608718",
"title": "A Single Arm Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) With Soft Tissue or Visceral Metastases",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pedro Barata, MD, MSc",
"sponsor_slug": "pedro-barata-md-msc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07538609",
"publication_url": "https://clinicaltrials.gov/study/NCT07538609",
"title": "The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study",
"has_exemption": false,
"start_date": "2026-10-07",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720219",
"publication_url": "https://clinicaltrials.gov/study/NCT07720219",
"title": "Obstructive Sleep Apnea Severity Reduction by AdIpose CryolysiS",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cryosa, Inc.",
"sponsor_slug": "cryosa-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07639684",
"publication_url": "https://clinicaltrials.gov/study/NCT07639684",
"title": "Metabolic Effects of Endoscopic Sleeve Gastroplasty in Obese Adults With Type 2 Diabetes: Evaluation of Glycemic Control, Insulin Use and Obesity Response",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07712757",
"publication_url": "https://clinicaltrials.gov/study/NCT07712757",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Safusidenib in Participants With Grade 2 Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvation Bio, Inc.",
"sponsor_slug": "nuvation-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769854",
"publication_url": "https://clinicaltrials.gov/study/NCT06769854",
"title": "Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chi Dang Hornik",
"sponsor_slug": "chi-dang-hornik",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06816433",
"publication_url": "https://clinicaltrials.gov/study/NCT06816433",
"title": "A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD",
"has_exemption": false,
"start_date": "2028-05-31",
"completion_date": "2029-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Global Coalition for Adaptive Research",
"sponsor_slug": "global-coalition-for-adaptive-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03258567",
"publication_url": "https://clinicaltrials.gov/study/NCT03258567",
"title": "Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2018-04-26",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548061",
"publication_url": "https://clinicaltrials.gov/study/NCT06548061",
"title": "Single Center Observational Study Using Spinal Laser Interstitial Thermal Therapy (sLITT) in the Treatment of Spine Metastases and Tumors",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06978088",
"publication_url": "https://clinicaltrials.gov/study/NCT06978088",
"title": "A Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zulfa Omer",
"sponsor_slug": "zulfa-omer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129993",
"publication_url": "https://clinicaltrials.gov/study/NCT07129993",
"title": "A Randomized, Open-Label, Phase 2/3 Study of Datopotamab Deruxtecan (Dato-DXd) Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Who Progressed During or After Enfortumab Vedotin (EV) Plus Pembrolizumab Combination Treatment TROPION-Urothelial03 (TU03)",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06816927",
"publication_url": "https://clinicaltrials.gov/study/NCT06816927",
"title": "A Multi-Center, Randomized, Phase 2 Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab (GIANT)",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06944145",
"publication_url": "https://clinicaltrials.gov/study/NCT06944145",
"title": "A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899764",
"publication_url": "https://clinicaltrials.gov/study/NCT05899764",
"title": "Epileptic Hippocampus in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07490600",
"publication_url": "https://clinicaltrials.gov/study/NCT07490600",
"title": "Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07541209",
"publication_url": "https://clinicaltrials.gov/study/NCT07541209",
"title": "A Phase 1/2 Open-label First-in-Human Dose-Escalating Safety and Efficacy Study Evaluating Subcutaneous Administration of PTH-IA in Adults and Children With Jansen s Metaphyseal Chondrodysplasia (JMC)",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Dental and Craniofacial Research (NIDCR)",
"sponsor_slug": "national-institute-of-dental-and-craniofacial-research-nidcr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099638",
"publication_url": "https://clinicaltrials.gov/study/NCT07099638",
"title": "Randomized Factorial Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07361484",
"publication_url": "https://clinicaltrials.gov/study/NCT07361484",
"title": "A Global, Multicenter, Randomized, Double-blinded, Phase 3 Study of Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer With EGFR, ALK, ROS, and RET Wild Type After Progressing on Prior Immunotherapy (Anti-PD-1/L1 Antibody) and Platinum-based Chemotherapy (DUBLIN-4)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "BeyondSpring Pharmaceuticals Inc.",
"sponsor_slug": "beyondspring-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07466498",
"publication_url": "https://clinicaltrials.gov/study/NCT07466498",
"title": "Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06863402",
"publication_url": "https://clinicaltrials.gov/study/NCT06863402",
"title": "Nemtabrutinib and Pembrolizumab in Patients With Richter Transformation: A Phase II Study",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07543172",
"publication_url": "https://clinicaltrials.gov/study/NCT07543172",
"title": "Phase II Study of CIMAVAX-EGF in Combination With KRAS G12C Inhibitors as Treatment for Advanced Stage KRAS G12C Mutated NSCLC",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07578649",
"publication_url": "https://clinicaltrials.gov/study/NCT07578649",
"title": "AN INTERVENTIONAL PHASE 3, OPEN LABEL, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH ADVANCED OR RECURRENT MISMATCH REPAIR PROFICIENT ENDOMETRIAL CANCER",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07229339",
"publication_url": "https://clinicaltrials.gov/study/NCT07229339",
"title": "Phase 2 Trial of Zipalertinib in Patients With Resectable Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion or Uncommon/Compound Mutations",
"has_exemption": false,
"start_date": "2027-06-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430332",
"publication_url": "https://clinicaltrials.gov/study/NCT07430332",
"title": "Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function",
"has_exemption": false,
"start_date": "2027-09-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011758",
"publication_url": "https://clinicaltrials.gov/study/NCT07011758",
"title": "Dynamic Treatment Regimes for Personalized Opioid Use Disorder Care",
"has_exemption": false,
"start_date": "2028-07-01",
"completion_date": "2029-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06900595",
"publication_url": "https://clinicaltrials.gov/study/NCT06900595",
"title": "A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer",
"has_exemption": false,
"start_date": "2026-02-22",
"completion_date": "2029-06-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286214",
"publication_url": "https://clinicaltrials.gov/study/NCT07286214",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica",
"has_exemption": false,
"start_date": "2026-05-12",
"completion_date": "2029-06-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632457",
"publication_url": "https://clinicaltrials.gov/study/NCT06632457",
"title": "A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis",
"has_exemption": false,
"start_date": "2024-11-07",
"completion_date": "2029-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07629440",
"publication_url": "https://clinicaltrials.gov/study/NCT07629440",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS",
"has_exemption": false,
"start_date": "2026-05-29",
"completion_date": "2029-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07595042",
"publication_url": "https://clinicaltrials.gov/study/NCT07595042",
"title": "A Phase 2C Trial of Stratified Patient-Centered Treatment Regimens for Active TB",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-06-05",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868290",
"publication_url": "https://clinicaltrials.gov/study/NCT06868290",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Active Granulomatosis With Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2029-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218510",
"publication_url": "https://clinicaltrials.gov/study/NCT07218510",
"title": "A Phase 2 Study of Venetoclax + Obinutuzumab Followed by Epcoritamab in Previously Untreated Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (LonGEVity)",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2029-06-08",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412120",
"publication_url": "https://clinicaltrials.gov/study/NCT06412120",
"title": "Single-Arm, Prospective, Multicenter Study Evaluating Safety, Tolerability, and Metabolism of Niraparib as Maintenance Following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2029-06-08",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564038",
"publication_url": "https://clinicaltrials.gov/study/NCT06564038",
"title": "A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination With Other Anticancer Agents in Participants With Mature B-Cell Malignancies",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2029-06-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06727773",
"publication_url": "https://clinicaltrials.gov/study/NCT06727773",
"title": "Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer",
"has_exemption": false,
"start_date": "2025-08-19",
"completion_date": "2029-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07623200",
"publication_url": "https://clinicaltrials.gov/study/NCT07623200",
"title": "A Phase 3, Randomized, Open-Label Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia and a CALR Mutation Previously Treated With Cytoreductive Therapy (EXCALIBUR-ET2)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-06-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05287126",
"publication_url": "https://clinicaltrials.gov/study/NCT05287126",
"title": "An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2022-12-16",
"completion_date": "2029-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06763328",
"publication_url": "https://clinicaltrials.gov/study/NCT06763328",
"title": "Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2029-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914128",
"publication_url": "https://clinicaltrials.gov/study/NCT06914128",
"title": "A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of BAY 3713372, a Novel 2nd Generation PRMT5 Inhibitor, in Participants With MTAP-deleted Solid Tumors.",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2029-06-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04368702",
"publication_url": "https://clinicaltrials.gov/study/NCT04368702",
"title": "Clinical Onboard Utilization of Image Guided Radiation Therapy With Magnetic Resonance (CONFIRM): A Master Protocol",
"has_exemption": false,
"start_date": "2021-05-01",
"completion_date": "2029-06-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276399",
"publication_url": "https://clinicaltrials.gov/study/NCT07276399",
"title": "A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants With Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2029-06-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03950232",
"publication_url": "https://clinicaltrials.gov/study/NCT03950232",
"title": "An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2019-09-05",
"completion_date": "2029-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013747",
"publication_url": "https://clinicaltrials.gov/study/NCT07013747",
"title": "A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Participants With Mild Acne",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2029-06-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042581",
"publication_url": "https://clinicaltrials.gov/study/NCT07042581",
"title": "Evaluation of Revaree Plus in Women With Breast Cancer",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-06-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477419",
"publication_url": "https://clinicaltrials.gov/study/NCT06477419",
"title": "Phase 2 Study of Sacituzumab Govitecan-hziy in Patients With Previously Treated Mesothelioma",
"has_exemption": false,
"start_date": "2024-06-21",
"completion_date": "2029-06-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852222",
"publication_url": "https://clinicaltrials.gov/study/NCT06852222",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A Rearrangements or NPM1 Mutations Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-06-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937229",
"publication_url": "https://clinicaltrials.gov/study/NCT06937229",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2029-06-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228273",
"publication_url": "https://clinicaltrials.gov/study/NCT07228273",
"title": "A Phase II Randomized Clinical Trial of Venetoclax Combined With FLAG IDA Induction and Consolidation Compared to Standard of Care for Newly Diagnosed Patients With Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-06-24",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07674732",
"publication_url": "https://clinicaltrials.gov/study/NCT07674732",
"title": "Nodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab Versus Short-course Radiotherapy Plus Chemotherapy as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer",
"has_exemption": false,
"start_date": "2026-06-24",
"completion_date": "2029-06-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Dechang Diao",
"sponsor_slug": "dechang-diao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07697599",
"publication_url": "https://clinicaltrials.gov/study/NCT07697599",
"title": "A Master Protocol for a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN7508 and REGN9933, Monoclonal Antibodies Against Factor XI, for Prophylaxis of Venous Thromboembolism in Participants With a Peripherally Inserted Central Catheter (PICC) (ROXI-PEAK)",
"has_exemption": false,
"start_date": "2026-08-20",
"completion_date": "2029-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07718672",
"publication_url": "https://clinicaltrials.gov/study/NCT07718672",
"title": "(PRESTO) A Randomized Phase II Trial Evaluating Hotspots in Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044337",
"publication_url": "https://clinicaltrials.gov/study/NCT06044337",
"title": "A Multicenter, Open-Label, Single-Arm, Phase 3, Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2029-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339423",
"publication_url": "https://clinicaltrials.gov/study/NCT07339423",
"title": "Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)",
"has_exemption": false,
"start_date": "2026-02-24",
"completion_date": "2029-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07658352",
"publication_url": "https://clinicaltrials.gov/study/NCT07658352",
"title": "An Open-label, First-in-human Dose Escalation and Dose Expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HP-002 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2029-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Helioson Pharmaceutical Co., Ltd.",
"sponsor_slug": "shanghai-helioson-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05847569",
"publication_url": "https://clinicaltrials.gov/study/NCT05847569",
"title": "Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Class Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07207811",
"publication_url": "https://clinicaltrials.gov/study/NCT07207811",
"title": "CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573970",
"publication_url": "https://clinicaltrials.gov/study/NCT06573970",
"title": "Atomoxetine Effect on Attention, Executive Function, and Quality of Life in Veterans With Posttraumatic Stress Disorder",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-06-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01624805",
"publication_url": "https://clinicaltrials.gov/study/NCT01624805",
"title": "Phase II Study of Horse Anti-Thymocyte Globulin (hATG), Cyclosporine, Methylprednisolone, and GCSF (Filgrastim or Pegfilgrastim) in Patients With Aplastic Anemia (AA), or Low/Int-1 Risk Myelodysplastic Syndrome (MDS)",
"has_exemption": false,
"start_date": "2012-06-25",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03887455",
"publication_url": "https://clinicaltrials.gov/study/NCT03887455",
"title": "A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2019-03-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04120493",
"publication_url": "https://clinicaltrials.gov/study/NCT04120493",
"title": "A Phase 1/2, Randomized, Double-Blind, Sham Control and Open-Label Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT-130) in Early Manifest Huntington's Disease",
"has_exemption": false,
"start_date": "2019-09-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "UniQure Biopharma B.V.",
"sponsor_slug": "uniqure-biopharma-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04296903",
"publication_url": "https://clinicaltrials.gov/study/NCT04296903",
"title": "Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)",
"has_exemption": false,
"start_date": "2020-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apifix",
"sponsor_slug": "apifix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04404660",
"publication_url": "https://clinicaltrials.gov/study/NCT04404660",
"title": "An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia",
"has_exemption": false,
"start_date": "2020-06-03",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Autolus Limited",
"sponsor_slug": "autolus-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04298723",
"publication_url": "https://clinicaltrials.gov/study/NCT04298723",
"title": "Randomized Comparison of Interventional Closure of the Left Atrial Appendage Using a LAA Closure Device Versus Oral Anticoagulation Therapy in Patients With Non-valvular Atrial Fibrillation and Status Post Intracranial Bleeding.",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jena University Hospital",
"sponsor_slug": "jena-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04293562",
"publication_url": "https://clinicaltrials.gov/study/NCT04293562",
"title": "A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations",
"has_exemption": false,
"start_date": "2020-07-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04671667",
"publication_url": "https://clinicaltrials.gov/study/NCT04671667",
"title": "A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features",
"has_exemption": false,
"start_date": "2021-04-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04889872",
"publication_url": "https://clinicaltrials.gov/study/NCT04889872",
"title": "The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement",
"has_exemption": false,
"start_date": "2021-10-12",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05268614",
"publication_url": "https://clinicaltrials.gov/study/NCT05268614",
"title": "Risk Adapted De-Intensification of Radio-Chemotherapy for Favorable Prognosis Oropharyngeal Squamous Cell Carcinoma Based on HPV Subtype and Plasma Circulating Free HPV DNA Level and Clearance Rate",
"has_exemption": false,
"start_date": "2022-05-16",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04128189",
"publication_url": "https://clinicaltrials.gov/study/NCT04128189",
"title": "Safety and Immunogenicity of Shingrix in Renal Transplant Recipients",
"has_exemption": false,
"start_date": "2023-03-02",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650658",
"publication_url": "https://clinicaltrials.gov/study/NCT05650658",
"title": "Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2023-09-13",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05609630",
"publication_url": "https://clinicaltrials.gov/study/NCT05609630",
"title": "A Multicenter, Randomized Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Upadacitinib With a Tocilizumab Reference Arm in Subjects From 1 Year to Less Than 18 Years Old With Active Systemic Juvenile Idiopathic Arthritis",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05863195",
"publication_url": "https://clinicaltrials.gov/study/NCT05863195",
"title": "A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial",
"has_exemption": false,
"start_date": "2023-10-19",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06060613",
"publication_url": "https://clinicaltrials.gov/study/NCT06060613",
"title": "A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Obsidian Therapeutics, Inc.",
"sponsor_slug": "obsidian-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06245889",
"publication_url": "https://clinicaltrials.gov/study/NCT06245889",
"title": "A Pilot Study of Neoadjuvant Response-Adapted Chemotherapy With Pembrolizumab in Patients With Stage 2 and 3 Triple Negative Breast Cancer to Determine Early PET and Biomarker Dynamics",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408181",
"publication_url": "https://clinicaltrials.gov/study/NCT06408181",
"title": "APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05711667",
"publication_url": "https://clinicaltrials.gov/study/NCT05711667",
"title": "Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315738",
"publication_url": "https://clinicaltrials.gov/study/NCT06315738",
"title": "Randomized, Controlled, Phase 1-2 Open Label Study of ST266 IV Administration to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Noveome Biotherapeutics, formerly Stemnion",
"sponsor_slug": "noveome-biotherapeutics-formerly-stemnion",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06486441",
"publication_url": "https://clinicaltrials.gov/study/NCT06486441",
"title": "A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470243",
"publication_url": "https://clinicaltrials.gov/study/NCT06470243",
"title": "A Phase III Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC), Stratified by Aggressive Variant Signature",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06641414",
"publication_url": "https://clinicaltrials.gov/study/NCT06641414",
"title": "A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascentage Pharma Group Inc.",
"sponsor_slug": "ascentage-pharma-group-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161974",
"publication_url": "https://clinicaltrials.gov/study/NCT06161974",
"title": "Phase 2 Study of Olutasidenib With Temozolomide as Maintenance Therapy in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor IDH1 Mutations",
"has_exemption": false,
"start_date": "2025-02-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigel Pharmaceuticals",
"sponsor_slug": "rigel-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06582875",
"publication_url": "https://clinicaltrials.gov/study/NCT06582875",
"title": "Advancing ADPKD Treatment With GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592586",
"publication_url": "https://clinicaltrials.gov/study/NCT06592586",
"title": "A Follow-up Trial to Assess the Persistence of the Immune Response to the Group B Streptococcus Vaccine (GBS-NN/NN2) After a Primary Vaccination of Healthy Pregnant Women, and to Assess Safety, Reactogenicity, and Immunogenicity of the GBS-NN/NN2 Vaccine When Administered During Follow-Up as a 1 Booster Dose During a New Pregnancy",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Minervax ApS",
"sponsor_slug": "minervax-aps",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06291064",
"publication_url": "https://clinicaltrials.gov/study/NCT06291064",
"title": "TreAtment Response and Omic-Markers in Triple-Negative Breast CAncer Patients Receiving Standard of Care Chemotherapy (TARMAC)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609369",
"publication_url": "https://clinicaltrials.gov/study/NCT06609369",
"title": "Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse",
"has_exemption": false,
"start_date": "2025-04-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953674",
"publication_url": "https://clinicaltrials.gov/study/NCT06953674",
"title": "Saline vs. Balanced Crystalloid in Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721819",
"publication_url": "https://clinicaltrials.gov/study/NCT06721819",
"title": "The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852469",
"publication_url": "https://clinicaltrials.gov/study/NCT06852469",
"title": "Individualized Computational Assessment of the Effects of GABA Receptor Modulation in Posttraumatic Stress Disorder",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940609",
"publication_url": "https://clinicaltrials.gov/study/NCT06940609",
"title": "Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation (MANIFEST)",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943755",
"publication_url": "https://clinicaltrials.gov/study/NCT06943755",
"title": "A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217860",
"publication_url": "https://clinicaltrials.gov/study/NCT07217860",
"title": "A Multicenter, Long-term, Open-Label, Safety, Tolerability, and Efficacy Study of Azetukalner in Bipolar I or II Depression",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xenon Pharmaceuticals Inc.",
"sponsor_slug": "xenon-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174310",
"publication_url": "https://clinicaltrials.gov/study/NCT07174310",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07211958",
"publication_url": "https://clinicaltrials.gov/study/NCT07211958",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed AML With an NPM1 Mutation",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Syndax Pharmaceuticals",
"sponsor_slug": "syndax-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116395",
"publication_url": "https://clinicaltrials.gov/study/NCT07116395",
"title": "Outcomes of Tranexamic Acid With Anticoagulants in Orthopaedic Trauma Procedures: A Prospective Study",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arbi Nazarian, MD",
"sponsor_slug": "arbi-nazarian-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287995",
"publication_url": "https://clinicaltrials.gov/study/NCT07287995",
"title": "A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-05",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07077395",
"publication_url": "https://clinicaltrials.gov/study/NCT07077395",
"title": "Finding Links Between Hot flASHes and CardioVascular Disease",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907173",
"publication_url": "https://clinicaltrials.gov/study/NCT06907173",
"title": "Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)",
"has_exemption": false,
"start_date": "2026-03-06",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339111",
"publication_url": "https://clinicaltrials.gov/study/NCT07339111",
"title": "Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis",
"has_exemption": false,
"start_date": "2026-03-11",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medipost, Inc.",
"sponsor_slug": "medipost-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06882772",
"publication_url": "https://clinicaltrials.gov/study/NCT06882772",
"title": "Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids, A Phase IIa Clinical Trial",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441876",
"publication_url": "https://clinicaltrials.gov/study/NCT07441876",
"title": "A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298447",
"publication_url": "https://clinicaltrials.gov/study/NCT07298447",
"title": "An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365332",
"publication_url": "https://clinicaltrials.gov/study/NCT07365332",
"title": "An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension (PAH)",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inhibikase Therapeutics",
"sponsor_slug": "inhibikase-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020832",
"publication_url": "https://clinicaltrials.gov/study/NCT07020832",
"title": "A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apellis Pharmaceuticals, Inc.",
"sponsor_slug": "apellis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811545",
"publication_url": "https://clinicaltrials.gov/study/NCT06811545",
"title": "Exploring the Effects of Multi-Joint Neuromuscular Electrical Stimulation on Training Gait of Children With Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290439",
"publication_url": "https://clinicaltrials.gov/study/NCT07290439",
"title": "Improving Maternal and Child Health Through Point-of-care STI Testing (MATCH-POINT)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07643012",
"publication_url": "https://clinicaltrials.gov/study/NCT07643012",
"title": "Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer: A Phase I/II Feasibility Study",
"has_exemption": false,
"start_date": "2026-06-09",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258290",
"publication_url": "https://clinicaltrials.gov/study/NCT07258290",
"title": "Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Teleflex",
"sponsor_slug": "teleflex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392957",
"publication_url": "https://clinicaltrials.gov/study/NCT07392957",
"title": "A Phase IB/II Open-label Study of the Safety and Preliminary Efficacy of CTX-009 Administered Either as a Monotherapy or in Combination With CTX-471 in Patients With Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2026-06-16",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07702578",
"publication_url": "https://clinicaltrials.gov/study/NCT07702578",
"title": "A Phase 1/3 Study Evaluating the Efficacy and Safety of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2026-06-18",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TScan Therapeutics, Inc.",
"sponsor_slug": "tscan-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284602",
"publication_url": "https://clinicaltrials.gov/study/NCT07284602",
"title": "A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PureTech",
"sponsor_slug": "puretech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07452224",
"publication_url": "https://clinicaltrials.gov/study/NCT07452224",
"title": "An Open-Label Phase II Study of ILKN421H in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-06-29",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "iLeukon Therapeutics, Inc.",
"sponsor_slug": "ileukon-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07306364",
"publication_url": "https://clinicaltrials.gov/study/NCT07306364",
"title": "Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07471139",
"publication_url": "https://clinicaltrials.gov/study/NCT07471139",
"title": "The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516444",
"publication_url": "https://clinicaltrials.gov/study/NCT07516444",
"title": "VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VDyne, Inc.",
"sponsor_slug": "vdyne-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07671534",
"publication_url": "https://clinicaltrials.gov/study/NCT07671534",
"title": "GEMINI: Phase II Study Using Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104318",
"publication_url": "https://clinicaltrials.gov/study/NCT07104318",
"title": "Randomized Clinical Trial of Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans: \"VA Eradicate HP\"",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720726",
"publication_url": "https://clinicaltrials.gov/study/NCT07720726",
"title": "The Impact of Pre-Operative Abobotulinumtoxin-A Injection on Paramedian Forehead Flap Donor Site Scar Aesthetics- A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07538804",
"publication_url": "https://clinicaltrials.gov/study/NCT07538804",
"title": "A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Preliminary Efficacy of ANS02 in Participants With EGFR Mutation-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-07-10",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avistone Biotechnology Co., Ltd.",
"sponsor_slug": "avistone-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960759",
"publication_url": "https://clinicaltrials.gov/study/NCT06960759",
"title": "Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Montana",
"sponsor_slug": "university-of-montana",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07572175",
"publication_url": "https://clinicaltrials.gov/study/NCT07572175",
"title": "SPARTACUS Trial (Sotagliflozin as Prevention of Antracycline-Related Toxicity in Adipose, Cardiac and mUskuloSkeletal Tissues)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07651319",
"publication_url": "https://clinicaltrials.gov/study/NCT07651319",
"title": "A Phase Ib Clinical Trial, Using Interleukin-2 (IL-2) and Semaglutide in Patients With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868238",
"publication_url": "https://clinicaltrials.gov/study/NCT06868238",
"title": "Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07691489",
"publication_url": "https://clinicaltrials.gov/study/NCT07691489",
"title": "A Phase 2 Trial of Trastuzumab Deruxtecan in Combination With Cetuximab in HER2-low Metastatic Colorectal Cancer That Has Progressed on Standard Therapies",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07655284",
"publication_url": "https://clinicaltrials.gov/study/NCT07655284",
"title": "STENT X Non-stent Genito-urinary Tract Reconstruction After Radical Cystectomy for Bladder Cancer - a Prospective, Randomized, Controlled and Multi Institutional Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07506863",
"publication_url": "https://clinicaltrials.gov/study/NCT07506863",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Subjects With α- or β- Transfusion-Dependent Thalassemia",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219238",
"publication_url": "https://clinicaltrials.gov/study/NCT07219238",
"title": "A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05809908",
"publication_url": "https://clinicaltrials.gov/study/NCT05809908",
"title": "A Phase 3, 26-Week, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Administration of Tricaprilin as AC-OLE-01-VA in Participants With Mild to Moderate Alzheimer's Disease Dementia",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerecin",
"sponsor_slug": "cerecin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05976802",
"publication_url": "https://clinicaltrials.gov/study/NCT05976802",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236542",
"publication_url": "https://clinicaltrials.gov/study/NCT06236542",
"title": "NextGen Tracheostomy Toolkit: Integrating Augmented and Virtual Reality With Robotics to Improve Tracheostomy Care",
"has_exemption": false,
"start_date": "2027-10-01",
"completion_date": "2029-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04071457",
"publication_url": "https://clinicaltrials.gov/study/NCT04071457",
"title": "S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04558736",
"publication_url": "https://clinicaltrials.gov/study/NCT04558736",
"title": "Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082063",
"publication_url": "https://clinicaltrials.gov/study/NCT06082063",
"title": "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Steno Diabetes Center Copenhagen",
"sponsor_slug": "steno-diabetes-center-copenhagen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364423",
"publication_url": "https://clinicaltrials.gov/study/NCT06364423",
"title": "Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for B-cell Leukemias",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328114",
"publication_url": "https://clinicaltrials.gov/study/NCT06328114",
"title": "Functional Magnetic Resonance Imaging (fMRI)-Guided Individualized Transcranial Magnetic Stimulation (TMS) for Cervical Dystonia",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06657976",
"publication_url": "https://clinicaltrials.gov/study/NCT06657976",
"title": "Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06650579",
"publication_url": "https://clinicaltrials.gov/study/NCT06650579",
"title": "Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02916810",
"publication_url": "https://clinicaltrials.gov/study/NCT02916810",
"title": "Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment",
"has_exemption": false,
"start_date": "2025-02-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06427798",
"publication_url": "https://clinicaltrials.gov/study/NCT06427798",
"title": "Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06837857",
"publication_url": "https://clinicaltrials.gov/study/NCT06837857",
"title": "Imaging, Cognition, and Opioids in Older Adults With Chronic Pain (I-COAP) Trial",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826859",
"publication_url": "https://clinicaltrials.gov/study/NCT06826859",
"title": "Dose Based Aspirin Pharmacokinetics and Pharmacodynamics in Pregnancy and Association With Pregnancy Outcomes",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013565",
"publication_url": "https://clinicaltrials.gov/study/NCT07013565",
"title": "NYMC623: A Comprehensive Risk-adapted Chemommunotherapy Protocol of Emerging Immunotherapies for Relapsed/Refractory Alk+ Anaplastic Large Cell Lymphoma (ACCELERATE)",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07601100",
"publication_url": "https://clinicaltrials.gov/study/NCT07601100",
"title": "A Phase 1b/2 Study of the Combination Isatuximab, Iberdomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible or Not Intended for Upfront Transplant",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05453851",
"publication_url": "https://clinicaltrials.gov/study/NCT05453851",
"title": "Total Pancreatectomy With Islet Cell Autotransplantation in Patients With Benign Pancreatic Neoplasms: A Pilot Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301346",
"publication_url": "https://clinicaltrials.gov/study/NCT07301346",
"title": "EASEE® System Pivotal Study for the United States of America",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Precisis US, Inc.",
"sponsor_slug": "precisis-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07570862",
"publication_url": "https://clinicaltrials.gov/study/NCT07570862",
"title": "A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe Systemic Lupus Erythematosus With Lupus Nephritis (RECLAIM-LN)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fate Therapeutics",
"sponsor_slug": "fate-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07609927",
"publication_url": "https://clinicaltrials.gov/study/NCT07609927",
"title": "The TrAnscatheter Venous Valve Endoprosthesis Clinical Investigation of Safety and Effectiveness for the enVVe® System",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hancock Jaffe Laboratiores, Inc",
"sponsor_slug": "hancock-jaffe-laboratiores-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602686",
"publication_url": "https://clinicaltrials.gov/study/NCT07602686",
"title": "MRI Evaluation of Local Anesthesia Administration",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06811038",
"publication_url": "https://clinicaltrials.gov/study/NCT06811038",
"title": "Providing Nicotine Replacement Therapy to Enhance the Efficacy of a Smoking Cessation Smartphone App for Hispanic Adults",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07655141",
"publication_url": "https://clinicaltrials.gov/study/NCT07655141",
"title": "A Phase 1/2 Trial Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of Subcutaneous ePGT121v1-LS in Combination With VRC07-523LS, Added to Standard Antiretroviral Therapy in Infants Living With HIV",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hospital Universitario 12 de Octubre",
"sponsor_slug": "hospital-universitario-12-de-octubre",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07655128",
"publication_url": "https://clinicaltrials.gov/study/NCT07655128",
"title": "A Phase 1/2 Trial Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of Subcutaneous ePGT121v1-LS, Added to Standard Antiretroviral Therapy in Infants Living With HIV",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hospital Universitario 12 de Octubre",
"sponsor_slug": "hospital-universitario-12-de-octubre",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06717347",
"publication_url": "https://clinicaltrials.gov/study/NCT06717347",
"title": "A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221474",
"publication_url": "https://clinicaltrials.gov/study/NCT07221474",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07706114",
"publication_url": "https://clinicaltrials.gov/study/NCT07706114",
"title": "Functional Electrical Stimulation: Effect on Walking in the Real World and Participation in Daily Life in People With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-07-02",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07602855",
"publication_url": "https://clinicaltrials.gov/study/NCT07602855",
"title": "A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-09-08",
"completion_date": "2029-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284745",
"publication_url": "https://clinicaltrials.gov/study/NCT07284745",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-09-11",
"completion_date": "2029-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07698535",
"publication_url": "https://clinicaltrials.gov/study/NCT07698535",
"title": "Dynamic Assessments of Molecular Response to Guide Early 177Lu-PSMA-617 Treatment Discontinuation: The DYNAMO Study",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-07-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07700160",
"publication_url": "https://clinicaltrials.gov/study/NCT07700160",
"title": "Phase 1/2a Open-label Clinical Trial Evaluating VBC108, a CLDN18.2 and CDH17-directed Bi-specific Antibody Drug Conjugate, in Participants With Advanced Malignant Solid Tumors",
"has_exemption": false,
"start_date": "2026-07-13",
"completion_date": "2029-07-07",
"has_results": false,
"results_due": false,
"sponsor_name": "VelaVigo Bio Inc",
"sponsor_slug": "velavigo-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06792825",
"publication_url": "https://clinicaltrials.gov/study/NCT06792825",
"title": "HM2023-43: A Phase 2 Trial of Tafasitamab in Combination With Lenalidomide+Rituximab in Treatment-naive Follicular Lymphoma and Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04606446",
"publication_url": "https://clinicaltrials.gov/study/NCT04606446",
"title": "A PHASE 1/2A DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTI-TUMOR ACTIVITY OF PF-07248144 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS",
"has_exemption": false,
"start_date": "2020-11-16",
"completion_date": "2029-07-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05092958",
"publication_url": "https://clinicaltrials.gov/study/NCT05092958",
"title": "MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs Maintenance Avelumab After First-Line Platinum-Based Chemotherapy in Patients With Metastatic Urothelial Cancer",
"has_exemption": false,
"start_date": "2022-06-03",
"completion_date": "2029-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07556939",
"publication_url": "https://clinicaltrials.gov/study/NCT07556939",
"title": "Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study)",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2029-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mitovation, Inc",
"sponsor_slug": "mitovation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06254482",
"publication_url": "https://clinicaltrials.gov/study/NCT06254482",
"title": "A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2023-08-25",
"completion_date": "2029-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07721259",
"publication_url": "https://clinicaltrials.gov/study/NCT07721259",
"title": "A Multiantigen Vaccine (STEMVAC) for Adjuvant Treatment of Patients With Moderate or Extensive Residual Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07667335",
"publication_url": "https://clinicaltrials.gov/study/NCT07667335",
"title": "A Phase Ib/II Study to Evaluate the Safety and Efficacy of Enfortumab Vedotin Plus Pembrolizumab in Combination With Quemliclustat in Unresectable Locally Advanced and Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-07-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07704099",
"publication_url": "https://clinicaltrials.gov/study/NCT07704099",
"title": "A Multicenter, Phase 2, Open-Label Study Evaluating the Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2026-09-14",
"completion_date": "2029-07-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Keros Therapeutics, Inc.",
"sponsor_slug": "keros-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090863",
"publication_url": "https://clinicaltrials.gov/study/NCT07090863",
"title": "Additively (AM) Versus Subtractively (SM) Manufactured Implant Supported Fixed Dental Prostheses (iFDPs)",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2029-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Harvard Medical School (HMS and HSDM)",
"sponsor_slug": "harvard-medical-school-hms-and-hsdm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07498426",
"publication_url": "https://clinicaltrials.gov/study/NCT07498426",
"title": "A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06528496",
"publication_url": "https://clinicaltrials.gov/study/NCT06528496",
"title": "N10: Reduced Therapy for High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-07-22",
"completion_date": "2029-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07567001",
"publication_url": "https://clinicaltrials.gov/study/NCT07567001",
"title": "Efficacy and Safety of NNC0487-0111 Compared to Placebo on Morbidity and Mortality in People With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity",
"has_exemption": false,
"start_date": "2026-05-11",
"completion_date": "2029-07-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07684599",
"publication_url": "https://clinicaltrials.gov/study/NCT07684599",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate GSK5733584 in Combination With Immune Checkpoint Inhibition for Maintenance Treatment of Participants With Mismatch Repair Proficient (MMRp) Endometrial Cancer",
"has_exemption": false,
"start_date": "2026-09-03",
"completion_date": "2029-07-23",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846281",
"publication_url": "https://clinicaltrials.gov/study/NCT06846281",
"title": "A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-07-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099391",
"publication_url": "https://clinicaltrials.gov/study/NCT07099391",
"title": "ALTITUDE - ALTernating Induction Therapies to Achieve Undetectable Disease Endpoints: A Phase 1/2 Alternating Dara-RVd/Teclistamab-RVd in Transplant Eligible Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2029-07-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06287775",
"publication_url": "https://clinicaltrials.gov/study/NCT06287775",
"title": "A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2029-07-25",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07675824",
"publication_url": "https://clinicaltrials.gov/study/NCT07675824",
"title": "A Phase 1/2 Study of REGN22530 in Participants With Primary Open Angle Glaucoma or Ocular Hypertension",
"has_exemption": false,
"start_date": "2026-07-23",
"completion_date": "2029-07-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07419295",
"publication_url": "https://clinicaltrials.gov/study/NCT07419295",
"title": "A Phase 3, Randomized, Open-label Study of Sacituzumab Tirumotecan (MK-2870) Versus Investigator's Choice of Non-platinum Chemotherapy in Participants With Pretreated Locally Advanced/Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2029-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444450",
"publication_url": "https://clinicaltrials.gov/study/NCT07444450",
"title": "A Phase 3, Randomized, Double-Blinded Study to Evaluate the Safety and Efficacy of Salanersen (BIIB115) After Onasemnogene Abeparvovec Treatment in Infants With Genetically Diagnosed Spinal Muscular Atrophy",
"has_exemption": false,
"start_date": "2026-09-04",
"completion_date": "2029-07-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157892",
"publication_url": "https://clinicaltrials.gov/study/NCT06157892",
"title": "A Phase 1b/2 Open-Label Study of Disitamab Vedotin in Combination With Other Anticancer Therapies in Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Seagen, a wholly owned subsidiary of Pfizer",
"sponsor_slug": "seagen-a-wholly-owned-subsidiary-of-pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097364",
"publication_url": "https://clinicaltrials.gov/study/NCT06097364",
"title": "A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948318",
"publication_url": "https://clinicaltrials.gov/study/NCT06948318",
"title": "A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults With Chronic Primary Immune Thrombocytopenia",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2029-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844449",
"publication_url": "https://clinicaltrials.gov/study/NCT05844449",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Year of Age and Older",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06981195",
"publication_url": "https://clinicaltrials.gov/study/NCT06981195",
"title": "Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07464912",
"publication_url": "https://clinicaltrials.gov/study/NCT07464912",
"title": "A Multicentre, Randomised, Double-blind, Placebo-controlled, Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Tide Pharmaceutical Co., Ltd",
"sponsor_slug": "beijing-tide-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07591610",
"publication_url": "https://clinicaltrials.gov/study/NCT07591610",
"title": "Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery: A Randomized Trial",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02307058",
"publication_url": "https://clinicaltrials.gov/study/NCT02307058",
"title": "A Phase II Randomized Trial of MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy - The Miami BLaStM Trial",
"has_exemption": false,
"start_date": "2015-02-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02081326",
"publication_url": "https://clinicaltrials.gov/study/NCT02081326",
"title": "Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02756962",
"publication_url": "https://clinicaltrials.gov/study/NCT02756962",
"title": "Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance",
"has_exemption": false,
"start_date": "2016-07-06",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960022",
"publication_url": "https://clinicaltrials.gov/study/NCT02960022",
"title": "A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study",
"has_exemption": false,
"start_date": "2016-12-22",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04349436",
"publication_url": "https://clinicaltrials.gov/study/NCT04349436",
"title": "An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)",
"has_exemption": false,
"start_date": "2020-05-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684862",
"publication_url": "https://clinicaltrials.gov/study/NCT04684862",
"title": "Combined Infusion System to Deliver Chemotherapy Regionally to the Liver",
"has_exemption": false,
"start_date": "2021-02-08",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ronald DeMatteo, M.D.",
"sponsor_slug": "ronald-dematteo-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05203172",
"publication_url": "https://clinicaltrials.gov/study/NCT05203172",
"title": "ENCORAFENIB/BINIMETINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05481879",
"publication_url": "https://clinicaltrials.gov/study/NCT05481879",
"title": "A Randomized, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2022-09-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05836987",
"publication_url": "https://clinicaltrials.gov/study/NCT05836987",
"title": "REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation",
"has_exemption": false,
"start_date": "2023-07-13",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05862272",
"publication_url": "https://clinicaltrials.gov/study/NCT05862272",
"title": "A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With Endometriosis",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma Switzerland GmbH",
"sponsor_slug": "sumitomo-pharma-switzerland-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06040255",
"publication_url": "https://clinicaltrials.gov/study/NCT06040255",
"title": "Focal Cerebral Arteriopathy Steroid Trial",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05968898",
"publication_url": "https://clinicaltrials.gov/study/NCT05968898",
"title": "Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules",
"has_exemption": false,
"start_date": "2024-01-09",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858009",
"publication_url": "https://clinicaltrials.gov/study/NCT04858009",
"title": "A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06213649",
"publication_url": "https://clinicaltrials.gov/study/NCT06213649",
"title": "Parasitic Ulcer Treatment Trial",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jeremy Keenan, MD, MPH",
"sponsor_slug": "jeremy-keenan-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06328777",
"publication_url": "https://clinicaltrials.gov/study/NCT06328777",
"title": "A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis",
"has_exemption": false,
"start_date": "2024-07-02",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06536413",
"publication_url": "https://clinicaltrials.gov/study/NCT06536413",
"title": "Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06171685",
"publication_url": "https://clinicaltrials.gov/study/NCT06171685",
"title": "MMRC Horizon One: A Phase II Randomized Adaptive Platform Trial Evaluating Novel Therapies in Relapsed or Refractory Multiple Myeloma (MMRC-099)",
"has_exemption": false,
"start_date": "2024-11-17",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734351",
"publication_url": "https://clinicaltrials.gov/study/NCT06734351",
"title": "A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712823",
"publication_url": "https://clinicaltrials.gov/study/NCT06712823",
"title": "An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia (CALM2-CAH)",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846463",
"publication_url": "https://clinicaltrials.gov/study/NCT06846463",
"title": "Phase 2 Trial Utilizing Zanubrutinib in Patients With Diffuse Large B-cell Lymphoma and MYD88 L265P Mutations, CD79B Mutations, NOTCH1 Truncation or Who Are CD5+ by IHC.",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026279",
"publication_url": "https://clinicaltrials.gov/study/NCT07026279",
"title": "A Phase 1b/2a, Multicenter, Open Label Study of the Safety, Efficacy and Pharmacokinetics of Narmafotinib in Combination With Modified FOLFIRINOX in Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amplia Therapeutics Limited",
"sponsor_slug": "amplia-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06274112",
"publication_url": "https://clinicaltrials.gov/study/NCT06274112",
"title": "Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Auburn University",
"sponsor_slug": "auburn-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201207",
"publication_url": "https://clinicaltrials.gov/study/NCT07201207",
"title": "Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satakunta Central Hospital",
"sponsor_slug": "satakunta-central-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06325202",
"publication_url": "https://clinicaltrials.gov/study/NCT06325202",
"title": "Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174583",
"publication_url": "https://clinicaltrials.gov/study/NCT07174583",
"title": "A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-10-14",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IDEAYA Biosciences",
"sponsor_slug": "ideaya-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247084",
"publication_url": "https://clinicaltrials.gov/study/NCT07247084",
"title": "A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221253",
"publication_url": "https://clinicaltrials.gov/study/NCT07221253",
"title": "Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227818",
"publication_url": "https://clinicaltrials.gov/study/NCT07227818",
"title": "A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994442",
"publication_url": "https://clinicaltrials.gov/study/NCT06994442",
"title": "Optimizing Pain Treatment in Children On Mechanical Ventilation",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157033",
"publication_url": "https://clinicaltrials.gov/study/NCT07157033",
"title": "A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xerient Pharma",
"sponsor_slug": "xerient-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287449",
"publication_url": "https://clinicaltrials.gov/study/NCT07287449",
"title": "A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dymicron",
"sponsor_slug": "dymicron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191327",
"publication_url": "https://clinicaltrials.gov/study/NCT07191327",
"title": "Testing Personalized High Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665074",
"publication_url": "https://clinicaltrials.gov/study/NCT06665074",
"title": "Inflammatory Challenge in Human Aggression.",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07055581",
"publication_url": "https://clinicaltrials.gov/study/NCT07055581",
"title": "A Phase II Study of Durvalumab Combined With EP Prior to Chemoradiotherapy and Followed by Durvalumab as Consolidation for Patients With Limited-stage Small-cell Lung Cancer (CONCUR Study)",
"has_exemption": false,
"start_date": "2026-02-24",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qian Chu",
"sponsor_slug": "qian-chu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285655",
"publication_url": "https://clinicaltrials.gov/study/NCT07285655",
"title": "A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Liquidia Technologies, Inc.",
"sponsor_slug": "liquidia-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07488676",
"publication_url": "https://clinicaltrials.gov/study/NCT07488676",
"title": "A Phase 1b/2 Open-label Study to Assess the Safety and Efficacy of ASP546C in Participants With CLDN18.2-expressing Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma, Pancreatic Adenocarcinoma or Other Solid Tumor Types",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07323524",
"publication_url": "https://clinicaltrials.gov/study/NCT07323524",
"title": "Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-05-19",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07277309",
"publication_url": "https://clinicaltrials.gov/study/NCT07277309",
"title": "Promoting Recovery After Brain Injury Using Focused Ultrasound",
"has_exemption": false,
"start_date": "2026-05-26",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07563881",
"publication_url": "https://clinicaltrials.gov/study/NCT07563881",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02129751",
"publication_url": "https://clinicaltrials.gov/study/NCT02129751",
"title": "A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch Health Americas, Inc.",
"sponsor_slug": "bausch-health-americas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594119",
"publication_url": "https://clinicaltrials.gov/study/NCT07594119",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07584369",
"publication_url": "https://clinicaltrials.gov/study/NCT07584369",
"title": "Short-term Effects of Methamphetamine on Residual Latent HIV Disease (EMRLHD) Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07688213",
"publication_url": "https://clinicaltrials.gov/study/NCT07688213",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 48-week SAR448851 Treatment Followed by Open-label Extension in Participants With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449975",
"publication_url": "https://clinicaltrials.gov/study/NCT07449975",
"title": "A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Diabetic Foot Ulcers",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "StimLabs",
"sponsor_slug": "stimlabs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07449988",
"publication_url": "https://clinicaltrials.gov/study/NCT07449988",
"title": "A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of Multiple Human Umbilical CORD-Based Skin Substitutes and Standard of Care Versus Standard of Care Alone in the Treatment of Hard-to-Heal Venous Leg Ulcers",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "StimLabs",
"sponsor_slug": "stimlabs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07490067",
"publication_url": "https://clinicaltrials.gov/study/NCT07490067",
"title": "Personalizing Heart Failure Treatment With Genomics: A Clinical Trial to Understand the Mechanisms and Validate a Polygenic Risk Score for Beta-Blocker Response",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593261",
"publication_url": "https://clinicaltrials.gov/study/NCT07593261",
"title": "MARACAS: A Phase II Trial of MRI-guided Adaptive Stereotactic RAdiotherapy in oligometastatiC Patients With Peritoneal Spread.",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
"sponsor_slug": "fondazione-policlinico-universitario-agostino-gemelli-irccs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07671365",
"publication_url": "https://clinicaltrials.gov/study/NCT07671365",
"title": "Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Methodist Healthcare System of San Antonio",
"sponsor_slug": "methodist-healthcare-system-of-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07702032",
"publication_url": "https://clinicaltrials.gov/study/NCT07702032",
"title": "A Randomized, Open-label, Phase 3 Trial of Petosemtamab in Combination With mFOLFOX6 or FOLFIRI Versus Cetuximab in Combination With mFOLFOX6 or FOLFIRI as First-line Treatment for Participants With RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919835",
"publication_url": "https://clinicaltrials.gov/study/NCT06919835",
"title": "CiLostAzol for pReventIon of Recurrent sTroke in Africa",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northern California Institute of Research and Education",
"sponsor_slug": "northern-california-institute-of-research-and-education",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07493252",
"publication_url": "https://clinicaltrials.gov/study/NCT07493252",
"title": "Actify! An mHealth Mood Management Tool to Improve Population-Level Smoking Cessation",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07526896",
"publication_url": "https://clinicaltrials.gov/study/NCT07526896",
"title": "Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Rhythm and Heart Failure",
"sponsor_slug": "medtronic-cardiac-rhythm-and-heart-failure",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07659743",
"publication_url": "https://clinicaltrials.gov/study/NCT07659743",
"title": "A Randomized, Double-blind, Sham-controlled, Parallel-group Trial Designed to Evaluate the Efficacy of BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07714395",
"publication_url": "https://clinicaltrials.gov/study/NCT07714395",
"title": "Phase 1/2 Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-Tumor Activity of Elraglusib Oral Tablets in Adult Participants With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Actuate Therapeutics Inc.",
"sponsor_slug": "actuate-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290530",
"publication_url": "https://clinicaltrials.gov/study/NCT07290530",
"title": "A 24-Month, Randomized, Double-Masked, Placebo-Controlled Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nacuity Pharmaceuticals, Inc.",
"sponsor_slug": "nacuity-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646563",
"publication_url": "https://clinicaltrials.gov/study/NCT05646563",
"title": "A Phase II, Open-Label Study of NM8074 in Soliris®-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07391774",
"publication_url": "https://clinicaltrials.gov/study/NCT07391774",
"title": "A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment for High Anatomic Stage ER-pos/HER2-neg Breast Cancer With RS≤25 (RxFINE-Low)",
"has_exemption": false,
"start_date": "2027-02-14",
"completion_date": "2029-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04539236",
"publication_url": "https://clinicaltrials.gov/study/NCT04539236",
"title": "A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mikkael Sekeres MD",
"sponsor_slug": "mikkael-sekeres-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05377177",
"publication_url": "https://clinicaltrials.gov/study/NCT05377177",
"title": "Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression (COMBAT-SI)",
"has_exemption": false,
"start_date": "2022-09-02",
"completion_date": "2029-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}